Elevation Oncology Inc (ELEV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELEV | AZN | AMGN | GILD | VRTX |
| Company | Elevation Oncology Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3120 | 69.58 | 271.34 | 107.25 | 435.76 |
| High | 0.3300 | 70.28 | 272.44 | 107.95 | 437.00 |
| Low | 0.3062 | 69.47 | 269.10 | 106.13 | 429.55 |
| Last | 0.3210 | 69.95 | 271.90 | 106.74 | 434.03 |
| Change | +0.0041 | +0.27 | +0.56 | -0.98 | -1.29 |
| % Change | +1.29% | +0.39% | +0.21% | -0.91% | -0.30% |
| Volume | 714,200 | 3,410,100 | 1,919,800 | 7,069,400 | 1,618,200 |
| 20-Day Average Volume | 857,895 | 5,390,270 | 2,895,905 | 9,411,005 | 2,155,080 |
| Previous Close | 0.3169 | 69.68 | 271.34 | 107.72 | 435.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3394 | 69.61 | 275.92 | 102.90 | 458.29 |
| 20-Day Raw Stochastic | 41.76% | 58.04% | 34.25% | 84.17% | 18.51% |
| 20-Day Relative Strength | 45.74% | 50.36% | 44.10% | 53.01% | 39.92% |
| Weighted Alpha | -72.12 | -10.61 | -13.76 | +56.06 | -9.04 |
| Today's Opinion | 88% Sell | 72% Sell | 88% Sell | 64% Buy | 56% Sell |
| Previous Opinion | 88% Sell | 72% Sell | 88% Sell | 64% Buy | 56% Sell |
| Last Month's Opinion | 80% Sell | 72% Sell | 56% Sell | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.07% since 05/15/25 | +2.93% since 05/15/25 | +0.08% since 05/15/25 | +6.38% since 05/15/25 | -0.08% since 05/15/25 |
| Low | 0.2716 on 05/16/25 | 68.08 on 05/16/25 | 267.73 on 05/16/25 | 100.23 on 05/16/25 | 429.55 on 05/22/25 |
| High | 0.3491 on 05/19/25 | 70.98 on 05/21/25 | 276.90 on 05/20/25 | 109.25 on 05/20/25 | 448.00 on 05/20/25 |
| 1-Month | |||||
| %Chg | -13.71% since 04/22/25 | +3.06% since 04/22/25 | -2.33% since 04/22/25 | +1.17% since 04/22/25 | -11.51% since 04/22/25 |
| Low | 0.2716 on 05/16/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 0.3900 on 04/23/25 | 72.69 on 05/06/25 | 292.00 on 04/30/25 | 109.25 on 05/20/25 | 510.77 on 04/30/25 |
| 3-Month | |||||
| %Chg | -47.15% since 02/21/25 | -5.75% since 02/21/25 | -10.27% since 02/21/25 | -2.92% since 02/21/25 | -10.37% since 02/21/25 |
| Low | 0.2210 on 04/09/25 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 0.6450 on 02/24/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -46.80% since 11/22/24 | +6.58% since 11/22/24 | -7.68% since 11/22/24 | +18.35% since 11/22/24 | -3.76% since 11/22/24 |
| Low | 0.2210 on 04/09/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
| High | 0.9800 on 01/13/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,768 | 216,094,896 | 145,901,136 | 133,996,032 | 111,788,872 |
| Shares Outstanding, K | 59,224 | 3,101,247 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -44,490,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | -14,210,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | 1.59 | 0.40 | 0.51 | 0.26 | 0.51 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 05/15/25 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 05/15/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.19 | 13.25 | 14.10 | 0.00 |